The opportunity in psychedelics for approved therapies could be much more expansive than it has been in cannabis…
EntheoTech holds over 200 exclusive psilocybin-containing mushroom strains and procedures in the extraction and implementation of these medicines, paving the way for EntheoTech to be one of the first companies in North America to provide a clinical trial-backed protocol and formula for natural macro and microdosing.